#Acid Suppression

|Property|Non-Particulate Antacids|Particulate Antacids|Proton Pump Inhibitors|H<sub>2</sub> receptor antagonists|
|---|---|
|**Example**|Sodium citrate|Aluminium Hydroxide/Calcium carbonate|Pantoprazole|Ranitidine
|**Uses**|Aspiration prophylaxis|Aspiration prophylaxis|Aspiration prophylaxis, GORD, peptic ulceration|Aspiration prophylaxis, GORD, peptic ulceration|
|**Absorption**|Rapid absorption due to high water solubility|Lower water solubility results in slower absorption and onset but no risk of alkalosis|Absorbed in small bowel|50% PO bioavailability
|**Distribution**||||Low protein binding
|**Metabolism**|||Hepatic by CYP450|Partial hepatic by CYP450
|**Elimination**|||Renal of metabolites and active drug|Renal of metabolites and active drug
|**Mechanism of Action**|Base reacts with gastric acid to produce salt and water|Base reacts with gastric acid to produce salt and water|Irreversible antagonism of the parietal H<sup>+</sup>/K<sup>+</sup> ATPase|Competitive antagonism of the (Gs) H<sub>2</sub> receptor, which ↓ cAMP production, ↓ intracellular Ca<sup>2+</sup>, and ↓ activity of the H<sup>+</sup>/K<sup>+</sup> ATPase
|**Resp**|Lower risk of pneumonitis if aspirated|Greater risk of pneumonitis if aspirated|Potentially increased severity of pneumonia if aspiration occurs (risk with microaspiration in long-term intubated patients)|Pneumonitis/pneumonia as per PPI
|**CVS**||||↓ HR, ↓ BP, and arrhythmogenic with rapid IV administration
|**Renal**|Potential metabolic alkalosis|No risk of alkalosis|||
|**GIT**|↑ Gastric pH|↑ Gastric pH|↑ Gastric pH, ↓ volume of secretions||
|**Other**|Taste bad||||


---

##References
Petkov
ANZCA Feb/April 2012